|4Jul 2, 8:08 PM ET

DARGAN CHARLES K 4

4 · BIOLARGO, INC. · Filed Jul 2, 2020

Insider Transaction Report

Form 4
Period: 2020-06-30
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to purchase common stock

    2020-06-30+5,0003,633,286 total
    Exercise: $0.16From: 2020-06-30Exp: 2030-06-30Common stock (5,000 underlying)
Footnotes (2)
  • [F1]This Option was granted to Reporting Person to replace options to purchase 20,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and the Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
  • [F2]This amount reflects, in addition to the reported option, grant, the expiration on May 31, 2020 and June 11, 2020, of options to purchase an aggregate 20,000 shares of common stock.

Documents

2 files